Merck Submits Biologics License Application to FDA for ROTATEQ®, an Investigational Vaccine for Rotavirus

Merck & Co, Inc announced today that it has submitted a Biologics License Application for ROTATEQ® (rotavirus vaccine, live, oral, pentavalent) to the U... click link for more info.

Continue to Merck Submits Biologics License Application to FDA for ROTATEQ®, an Investigational Vaccine for Rotavirus on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz